Rigel Pharmaceuticals (RIGL) FCF Margin Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 2,026.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,026.00 |
| Dec 31, 2025 | 7,437.00 |
| Sep 30, 2025 | 9,479.00 |
| Jun 30, 2025 | 7,321.00 |
| Mar 31, 2025 | 15,286.00 |
| Dec 31, 2024 | 11,855.00 |
| Sep 30, 2024 | 8,778.00 |
| Jun 30, 2024 | -20,785.00 |
| Mar 31, 2024 | 774.00 |
| Dec 31, 2023 | 6,970.00 |
| Sep 30, 2023 | 10,217.00 |
| Jun 30, 2023 | 10,940.00 |
| Mar 31, 2023 | -899.00 |
| Dec 31, 2022 | 2,376.00 |
| Sep 30, 2022 | 1,169.00 |
| Jun 30, 2022 | 11,793.00 |
| Mar 31, 2022 | -14,704.00 |
| Dec 31, 2021 | -12,399.00 |
| Sep 30, 2021 | 36,741.00 |
| Jun 30, 2021 | 175,752.00 |
| Dec 31, 2020 | -52,799.00 |
| Sep 30, 2020 | 185,588.00 |
| Mar 31, 2020 | 57,381.00 |
| Dec 31, 2019 | 34,904.00 |
| Sep 30, 2019 | 53,511.00 |
| Jun 30, 2019 | 5,601.00 |
| Mar 31, 2019 | 44,470.00 |
| Dec 31, 2018 | 19,376.00 |
| Sep 30, 2018 | -34,086.00 |
| Jun 30, 2018 | -119,741.00 |
| Dec 31, 2016 | -8,401.00 |
| Jun 30, 2016 | 132,360.00 |
| Jun 30, 2015 | 108,575.00 |
| Mar 31, 2015 | 413,731.00 |